Professor Ziyad Al-Aly
Dr. Al-Aly a physician-scientist; he directs the Clinical Epidemiology Center and serves as the Chief of Research and Development Service at the VA Saint Louis Health Care System. He is a senior clinical epidemiologist at Washington University in Saint Louis. He is internationally recognized for his expertise in harnessing the power of big data to answer important public health questions.
He led work which provided systematic characterization of the post-acute sequelae of SARS-CoV-2 infection (also called Long Covid) and subsequently characterization of the increased risks of cardiovascular disease, neurologic disorders, diabetes, dyslipidemia, kidney disease, and gastrointestinal disorders following SARS-CoV-2 infection. His lab was the first to produce evidence characterizing the effects of vaccines on Long Covid, the health consequences of repeated infections with SARS-CoV-2, and the effect of antivirals on the short- and long-term outcomes of SARS-CoV-2 infection. Dr. Al-Aly co-chaired the Biden-Harris Administration committee that developed the National Research Action Plan for Long Covid and serves on the US Government Interagency Long Covid Coordination Council. He advised the Chief Science Advisor of Canada (Government of Justin Trudeau). He currently serves on a consensus committee at the National Academy of Sciences, Engineering, and Medicine looking at the long-term health effects stemming from COVID-19 and their implications for the Social Security Administration.
Profile (describing upbringing and research journey): https://outlook.wustl.edu/real-world-reflections/